MIC
Means Investment Company’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $833K | Sell |
6,583
-2,740
| -29% | -$347K | 0.08% | 100 |
|
2025
Q1 | $1.19M | Sell |
9,323
-997
| -10% | -$128K | 0.13% | 80 |
|
2024
Q4 | $1.36M | Buy |
10,320
+914
| +10% | +$121K | 0.14% | 81 |
|
2024
Q3 | $1.37M | Sell |
9,406
-137
| -1% | -$19.9K | 0.15% | 78 |
|
2024
Q2 | $1.31M | Sell |
9,543
-612
| -6% | -$84K | 0.16% | 77 |
|
2024
Q1 | $1.39M | Buy |
10,155
+16
| +0.2% | +$2.2K | 0.18% | 75 |
|
2023
Q4 | $1.38M | Sell |
10,139
-2,447
| -19% | -$332K | 0.2% | 75 |
|
2023
Q3 | $1.54M | Sell |
12,586
-269
| -2% | -$32.9K | 0.25% | 66 |
|
2023
Q2 | $1.63M | Buy |
12,855
+518
| +4% | +$65.8K | 0.26% | 70 |
|
2023
Q1 | $1.59M | Buy |
12,337
+549
| +5% | +$70.9K | 0.28% | 67 |
|
2022
Q4 | $1.55M | Buy |
11,788
+484
| +4% | +$63.5K | 0.31% | 70 |
|
2022
Q3 | $1.32M | Buy |
11,304
+1,444
| +15% | +$169K | 0.29% | 72 |
|
2022
Q2 | $1.16M | Buy |
9,860
+1,326
| +16% | +$156K | 0.25% | 82 |
|
2022
Q1 | $1.11M | Buy |
8,534
+1,003
| +13% | +$131K | 0.2% | 81 |
|
2021
Q4 | $1.15M | Buy |
7,531
+3,544
| +89% | +$541K | 0.2% | 78 |
|
2021
Q3 | $645K | Sell |
3,987
-1,294
| -25% | -$209K | 0.13% | 99 |
|
2021
Q2 | $864K | Buy |
5,281
+157
| +3% | +$25.7K | 0.17% | 85 |
|
2021
Q1 | $771K | Buy |
5,124
+378
| +8% | +$56.9K | 0.18% | 85 |
|
2020
Q4 | $806K | Buy |
4,746
+817
| +21% | +$139K | 0.18% | 80 |
|
2020
Q3 | $541K | Buy |
3,929
+309
| +9% | +$42.5K | 0.15% | 86 |
|
2020
Q2 | $477K | Buy |
3,620
+59
| +2% | +$7.77K | 0.15% | 88 |
|
2020
Q1 | $440K | Buy |
3,561
+359
| +11% | +$44.4K | 0.17% | 79 |
|
2019
Q4 | $390K | Buy |
3,202
+3
| +0.1% | +$365 | 0.13% | 99 |
|
2019
Q3 | $350K | Sell |
3,199
-566
| -15% | -$61.9K | 0.13% | 103 |
|
2019
Q2 | $410K | Buy |
3,765
+67
| +2% | +$7.3K | 0.17% | 92 |
|
2019
Q1 | $413K | Buy |
3,698
+890
| +32% | +$99.4K | 0.18% | 89 |
|
2018
Q4 | $271K | Buy |
+2,808
| New | +$271K | 0.15% | 108 |
|